Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy

Oncology Reviews
Sonu Kumar GuptaMalkhey Verma

Abstract

One of the major problems being faced by researchers and clinicians in leukemic treatment is the development of multidrug resistance (MDR) which restrict the action of several tyrosine kinase inhibitors (TKIs). MDR is a major obstacle to the success of cancer chemotherapy. The mechanism of MDR involves active drug efflux transport of ABC superfamily of proteins such as Pglycoprotein (P-gp/ABCB1), multidrug resistance-associated protein 2 (MRP2/ABCC2), and breast cancer resistance protein (BCRP/ABCG2) that weaken the effectiveness of chemotherapeutics and negative impact on the future of anticancer therapy. In this review, the authors aim to provide an overview of various multidrug resistance (MDR) mechanisms observed in cancer cells as well as the various strategies developed to overcome these MDR. Extensive studies have been carried out since last several years to enhance the efficacy of chemotherapy by defeating these MDR mechanisms with the use of novel anticancer drugs that could escape from the efflux reaction, MDR modulators or chemosensitizers, multifunctional nanotechnology, and RNA interference (RNAi) therapy.

References

Jul 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·E B Mechetner, I B Roninson
Jan 1, 1991·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·P R Twentyman, N M Bleehen
Oct 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·H Hamada, T Tsuruo
Apr 14, 2000·American Journal of Physiology. Gastrointestinal and Liver Physiology·T CantzD Keppler
Aug 17, 2000·Journal of the National Cancer Institute·P BorstJ Wijnholds
Sep 27, 2000·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M V St-PierreJ J Marin
Oct 18, 2000·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·R Krishna, L D Mayer
Jul 11, 2001·Pharmacotherapy·C J MathenyG M Pollack
Dec 14, 2001·Journal of Medicinal Chemistry·T J AltstadtM D Wittman
Mar 1, 2002·The New England Journal of Medicine·Hagop KantarjianUNKNOWN International STI571 CML Study Group
May 9, 2002·Drug Metabolism Reviews·Richard B Kim
Jun 8, 2002·Breast Cancer Research : BCR·John W Park
Jan 22, 2003·Advanced Drug Delivery Reviews·Alfred H Schinkel, Johan W Jonker
Mar 15, 2003·The New England Journal of Medicine·Stephen G O'BrienUNKNOWN IRIS Investigators
Apr 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Hilary Thomas, Helen M Coley
Sep 19, 2003·Biochemical and Biophysical Research Communications·Robert Roskoski
Oct 11, 2005·Critical Reviews in Oncology/hematology·Christoph Walz, Martin Sattler
Nov 25, 2005·Current Drug Delivery·Hristos GlavinasBalázs Sarkadi
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Jul 19, 2006·Pflügers Archiv : European journal of physiology·Anne T Nies, Dietrich Keppler
Jul 26, 2006·Expert Opinion on Drug Metabolism & Toxicology·Gabriele JedlitschkyHeyo K Kroemer
Feb 1, 2007·Nucleic Acids Research·Michael FisherPiet Herdewijn
Mar 24, 2007·Experimental Hematology·Michael W N Deininger
Apr 13, 2007·Expert Review of Anticancer Therapy·Elizabeth Fox, Susan E Bates
Oct 13, 2007·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T Fojo, M Menefee
Mar 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwangjae ChoDong M Shin
May 20, 2008·Expert Opinion on Drug Metabolism & Toxicology·Anne T NiesDietrich Keppler
Jun 27, 2008·Cellular and Molecular Life Sciences : CMLS·H Lage

❮ Previous
Next ❯

Citations

Jan 16, 2021·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Zhuo-Xun WuYihang Pan
Jul 28, 2021·Pharmacological Reviews·Trevor M PenningTea Lanišnik Rižner
Apr 14, 2021·Current Drug Targets·Maria Manuela EstevinhoJoão Carvalho
Nov 3, 2021·Nano Convergence·Jessica A Kemp, Young Jik Kwon

❮ Previous
Next ❯

Methods Mentioned

BETA
transfection

Related Concepts

Related Feeds

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.